MA

Mable

YC S21 ↗

London, GB · Founded 2019 · 7 employees · Acquired · 4 known investors

trymable.com ↗

Mable is a genomics-based telehealth platform that provides personalized migraine care by analyzing patients' genetic and biomarker data to inform individualized treatment plans. The company serves migraine sufferers seeking precision medicine alternatives to traditional trial-and-error medication approaches.

Founders & leadership· Y Combinator alumni (S21)

RR

Roman RothaermelinFounder

IT

Inna ThalmanninFounder

CE

Chris Eijsbouts

KG

Kumeren Govnder

Investors · 4

IN

Initialized Capital✓ verifiedSan Francisco · $1M – $5M

UN

Underscore VCBoston

Y

Y CombinatorSan Francisco · $500K

VE

VenrockreportedPalo Alto · $500K – $10M